We repeated a similar experiment by co-culturing HT29 cancer cells with hepatocytes in the presence of LSKL (Leucine-Serine-Lysine-Leucine), an inhibitor of TSP1-mediated TGFβ1 activation66,67. This evidence concerns the gene TGFB1 and cancer.